Cargando…
The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy
Objectives. This study observes therapeutic efficacy of uterine artery embolization combined with MTX infusion which terminates cesarean scar pregnancy (CSP) and induces three factors which probably relate to failure. Methods. Twenty-three CSP patients were treated with combined uterine artery MTX i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824810/ https://www.ncbi.nlm.nih.gov/pubmed/24282376 http://dx.doi.org/10.1155/2013/213603 |
_version_ | 1782290745697239040 |
---|---|
author | An, Xiao Ming, Xu Li, Ke Wang, Jingbing |
author_facet | An, Xiao Ming, Xu Li, Ke Wang, Jingbing |
author_sort | An, Xiao |
collection | PubMed |
description | Objectives. This study observes therapeutic efficacy of uterine artery embolization combined with MTX infusion which terminates cesarean scar pregnancy (CSP) and induces three factors which probably relate to failure. Methods. Twenty-three CSP patients were treated with combined uterine artery MTX infusion and embolization. Among them six patients with severe hemorrhage were immediately treated with interventional operation. Clinical effects were estimated by symptoms, serum β-hCG, ultrasound, and MR. Results. Interventional treatments were technologically successful in 22 patients except one. Immediate hemostasis was achieved in all 6 patients with massive colporrhagia. No occurrence of infection and uterine necrosis was observed, but 12 women suffered abdominal pains. Nineteen patients' uteri were preserved, whereas four underwent hysterectomy eventually. Conclusions. Transcatheter arterial chemoembolization is effective to treat high-risk CSP in preference to hysterectomy. To achieve more successful outcomes, three factors should be highlighted: adequate MTX dosage, appropriate embolic material, and complete embolization of target arteries that supply blood to embryo in the scar. |
format | Online Article Text |
id | pubmed-3824810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38248102013-11-26 The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy An, Xiao Ming, Xu Li, Ke Wang, Jingbing ScientificWorldJournal Clinical Study Objectives. This study observes therapeutic efficacy of uterine artery embolization combined with MTX infusion which terminates cesarean scar pregnancy (CSP) and induces three factors which probably relate to failure. Methods. Twenty-three CSP patients were treated with combined uterine artery MTX infusion and embolization. Among them six patients with severe hemorrhage were immediately treated with interventional operation. Clinical effects were estimated by symptoms, serum β-hCG, ultrasound, and MR. Results. Interventional treatments were technologically successful in 22 patients except one. Immediate hemostasis was achieved in all 6 patients with massive colporrhagia. No occurrence of infection and uterine necrosis was observed, but 12 women suffered abdominal pains. Nineteen patients' uteri were preserved, whereas four underwent hysterectomy eventually. Conclusions. Transcatheter arterial chemoembolization is effective to treat high-risk CSP in preference to hysterectomy. To achieve more successful outcomes, three factors should be highlighted: adequate MTX dosage, appropriate embolic material, and complete embolization of target arteries that supply blood to embryo in the scar. Hindawi Publishing Corporation 2013-10-24 /pmc/articles/PMC3824810/ /pubmed/24282376 http://dx.doi.org/10.1155/2013/213603 Text en Copyright © 2013 Xiao An et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study An, Xiao Ming, Xu Li, Ke Wang, Jingbing The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy |
title | The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy |
title_full | The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy |
title_fullStr | The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy |
title_full_unstemmed | The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy |
title_short | The Analysis of Efficacy and Failure Factors of Uterine Artery Methotrexate Infusion and Embolization in Treatment of Cesarean Scar Pregnancy |
title_sort | analysis of efficacy and failure factors of uterine artery methotrexate infusion and embolization in treatment of cesarean scar pregnancy |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824810/ https://www.ncbi.nlm.nih.gov/pubmed/24282376 http://dx.doi.org/10.1155/2013/213603 |
work_keys_str_mv | AT anxiao theanalysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy AT mingxu theanalysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy AT like theanalysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy AT wangjingbing theanalysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy AT anxiao analysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy AT mingxu analysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy AT like analysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy AT wangjingbing analysisofefficacyandfailurefactorsofuterinearterymethotrexateinfusionandembolizationintreatmentofcesareanscarpregnancy |